chr2-218072411-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_198483.4(RUFY4):āc.191G>Cā(p.Arg64Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000095 in 1,537,390 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_198483.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RUFY4 | NM_198483.4 | c.191G>C | p.Arg64Pro | missense_variant | 5/13 | ENST00000697321.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RUFY4 | ENST00000697321.1 | c.191G>C | p.Arg64Pro | missense_variant | 5/13 | NM_198483.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000539 AC: 82AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000120 AC: 17AN: 142184Hom.: 0 AF XY: 0.000158 AC XY: 12AN XY: 76104
GnomAD4 exome AF: 0.0000462 AC: 64AN: 1385084Hom.: 0 Cov.: 31 AF XY: 0.0000454 AC XY: 31AN XY: 683478
GnomAD4 genome AF: 0.000538 AC: 82AN: 152306Hom.: 0 Cov.: 32 AF XY: 0.000470 AC XY: 35AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 30, 2021 | The c.191G>C (p.R64P) alteration is located in exon 5 (coding exon 3) of the RUFY4 gene. This alteration results from a G to C substitution at nucleotide position 191, causing the arginine (R) at amino acid position 64 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at